Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: A KONSAR Study in 2002

Yonsei Medical Journal

Volumn 45, Issue 4, 2004, Pages 598-608

  Lee, Kyungwon ^a   Kim, Young Ah ^b   Park, Yeon Joon ^c   Lee, Hye Soo ^d   Kim, Moon Yeun ^e   Kim, Eui Chong ^f   Yong, Dongeun ^a   Chong, Yunsop ^a   Kim, Jae Seok ^g   Kim, Sunjoo ^h   Ryoo, Namhee ⁱ   Jeong, Hoo ^j   Ha, Gyoung Yim ^k   Chang, Chulhun L ^l   Park, Ki Hyung ^m   Lee, Nam Yong ⁿ   Kim, Myungshin ^o   Kim, Jeong Ho ^p   Jeong, Joseph ^q   Cho, Ji Hyun ^r   Uh, Young ^s   Hong, Ki Sook ^t   Shin, Moon Bo ^u   Kim, Jin Ju ^v   Jang, Sook Jin ^w   Park, Ae Ja ^x   Cha, Young Joo ^y   Choi, Young Jin ^z   Kang, Ha ^aa   Rhim, Chang Hyun ^ab   Lee, Myung Hee ^ac   Song, Wonkeun ^g   Choi, Tae Yeal ^ad   Kang, Jung Oak ^ad   Shin, Jong Hee ^ae   Hong, Seong Geun ^af   Lee, Hee Joo ^ag   Lim, Hwan Sub ^ah   Kang, Hee Jung ^aa   Kim, Hyun Kyung ^ai   Lee, Miae ^aj   more..

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Chonbuk National University Medical School   (South Korea)

^e Dongguk University   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g Hallym University College of Medicine   (South Korea)

^h Gyeongsang National University   (South Korea)

ⁱ Keimyung University   (South Korea)

^j Kosin University   (South Korea)

^k Dongguk University Gyeongju Hospital   (South Korea)

^l Pusan National University School of Medicine   (South Korea)

^m Busan Medical Center   (South Korea)

ⁿ Sungkyunkwan University School of Medicine   (South Korea)

^o The Catholic University of Korea   (South Korea)

^p Yonsei University College of Medicine   (South Korea)

^q Ulsan University College of Medicine   (South Korea)

^r Wonkwang University Hospital   (South Korea)

^s Yonsei University Wonju   (South Korea)

^t Ewha Womans University   (South Korea)

^u Inje University College of Medicine   (South Korea)

^v Inha University Hospital   (South Korea)

^w Chosun University   (South Korea)

^x Chung Ang University   (South Korea)

^y Chung Ang University   (South Korea)

^z Soonchunhyang University College of Medicine   (South Korea)

^aa Hallym University   (South Korea)

^ab Wallace Memorial Baptist Hospital   (South Korea)

^ac Korea Veterans' Hospital   (South Korea)

^ad Hanyang University   (South Korea)

^ae Chonnam National University Medical School   (South Korea)

^af CHA University   (South Korea)

^ag Kyung Hee University College of Medicine   (South Korea)

^ah Catholic Kwandong University   (South Korea)

^ai National Cancer Center   (South Korea)

^aj Mokdong Hospital   (South Korea)

more..

Author keywords

Antimicrobial resistance; Imipenem resistance; Korean resistance surveillance

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HEALTH SURVEY; KLEBSIELLA PNEUMONIAE; KOREA; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATIENT CARE; PREVALENCE; PSEUDOMONAS AERUGINOSA; SALMONELLA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 4644320433     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.4.598     Document Type: Article

References (32)

1. Hunter PA, Reeves DS. The current status of surveillance of resistance to antimicrobial agents: report on a meeting. J Antimicrob Chemother 2002;49:17-23.
2. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 2003;36:S11-23.
3. Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004;10:349-83.
4. Bhavnani SM, Hammel JP, Forrest A, Jones RN, Ambrose PG. Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens. Clin Infect Dis 2003;37:344-50.
5. Lee K, Jang SJ, Lee HJ, Ryoo N, Kim M, Hong SG, et al. Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001. J Korean Med Sci 2004;19:8-14.
6. Lee K, Lee WG, Uh Y, Ha GY, Cho J, Chong Y, et al. VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis 2003;9:868-71.
7. Lee K, Ha GY, Shin BM, Kim JJ, Kang JO, Jang SJ, et al. Metallo-(-lactamase-producing Gram-negative bacilli in KONSAR group hospitals in 2003: continued prevalence of VIM-2-producing Pseudomonas spp. and increase of IMP-1-producing Acinetobacter spp. Diag Microb Infect Dis (in Press 2004)
8. Morris AK, Masterton RG. Antibiotic resistance surveillance: action for international studies. J Antimicrob Chemother 2002;49:7-10.
9. Lee K, Kim MY, Kang SH, Kang JO, Kim EC, Choi TY, et al. Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in Gram-negative bacilli. Yonsei Med J 2003;44:571-8.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: tenth informational supplement, Wayne, PA, NCCLS, 2000.
11. Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RP, et al. Temporal changes in prevalence of antimicrobial resistance in 23 U.S. hospitals. Emerg Infect Dis 2002; 8:697-701.
12. Bax R, Bywater R, Cornaglia G, Goosens H, Hunter P, Isham V, et al. Surveillance of antimicrobial resistance-what, how and whither? Clin Microbiol Infect 2001;7: 316-25.
13. National Committee for Clinical Laboratory Standards. Analysis and presentation of cumulative antimicrobial susceptibility test data. Approved guideline M39-A. Wayne, PA, NCCLS, 2002.
14. Halstead DC, Gomez N, McCarter YS. Reality of developing a community-wide antibiogram. J Clin Microbiol 2004;42:1-6.
15. Thouverez M, Talon D. Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France. Clin Microbiol Infect 2004;10:441-7.
16. Pai H, Choi EW, Lee HJ, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 2001;39: 3747-9.
17. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
18. Kim HB, Jang HC, Nam HJ, Lee YS, Kim BS, Park WB, et al. In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary- care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother 2004;48:1124-7.
19. Sunada A, Asari S. Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penicillin resistant Streptococcus pneumoniae between 1998 and 2000 in the Kinki district. J Jap Assoc Infect Dis 2003; 77:331-9.
20. Kacica M. Vancomycin-resistant Staphylococcus aureus-New York. Morb Mortal Wkly Rep 2004; 53:322-3.
21. Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu W, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for surveillance of resistant pathogens (ANSORP) study. Clin Infect Dis;28:1206-11.
22. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998;26:811-38.
23. Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 2004;53:457-63.
24. Inoue M, Lee NY, Hong SW, Lee K, Felmingham D. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents 2004;23:44-51.
25. Hasegawa K, Chiba N, Kobayashi R, Murayama SY, Iwata S, Sunakawa K, et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob Agents Chemother 2004;48: 1509-14.
26. Park MS, Kang YH, Lee SJ, Song CY, Lee BK. Characteristics of epidemic multidrug-resistant Salmonella enterica serovar Typhimurium DT104 strains first isolated in Korea. Korean J Infect Dis 2002;34:1-8.
27. Hooper DC. The future of the quinolones. APUA Newsletter 2001;19:1-5.
28. Song W, Kim JS, Kim MN, Kim EC, Park YJ, Yong D, et al. Occurrence and genotypic distributions of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea. Korean J Lab Med 2002;22:410-6.
29. Huh JY, Lee WG, Lee K, Shin WS, Yoo JH. Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. J Clin Microbiol 2004;42:1897-902.
30. Bauernfeind A, Chong Y, Lee K. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after the discovery? Yonsei Med J 1998;39:520-5.
31. Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases. Antimicrob Agents Chemother 1997;41:223-32.
32. WHO Network on Antimicrobial Resistance Monitoring. Focal point data (2003). Antimicrobial Resistance Newsletter 2004:12:1-2.